HUT70036A - N-[[2-amino-4-substituted-pyrrolo[2,3-d]pyrimidinyl-or pyrido[2,3-d]pyrimidinyl]-alkyl-benzoyl]-l-glutamic-acid derivatives, process for producing them and pharmaceutical preparations containing them - Google Patents

N-[[2-amino-4-substituted-pyrrolo[2,3-d]pyrimidinyl-or pyrido[2,3-d]pyrimidinyl]-alkyl-benzoyl]-l-glutamic-acid derivatives, process for producing them and pharmaceutical preparations containing them Download PDF

Info

Publication number
HUT70036A
HUT70036A HU9300804A HU9300804A HUT70036A HU T70036 A HUT70036 A HU T70036A HU 9300804 A HU9300804 A HU 9300804A HU 9300804 A HU9300804 A HU 9300804A HU T70036 A HUT70036 A HU T70036A
Authority
HU
Hungary
Prior art keywords
pyrrolo
amino
pharmaceutically acceptable
compound
acceptable salt
Prior art date
Application number
HU9300804A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9300804D0 (en
Inventor
Lynn Stacy Gossett
Chuan Shih
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HU9300804D0 publication Critical patent/HU9300804D0/hu
Publication of HUT70036A publication Critical patent/HUT70036A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9300804A 1992-03-24 1993-03-19 N-[[2-amino-4-substituted-pyrrolo[2,3-d]pyrimidinyl-or pyrido[2,3-d]pyrimidinyl]-alkyl-benzoyl]-l-glutamic-acid derivatives, process for producing them and pharmaceutical preparations containing them HUT70036A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/856,611 US5196424A (en) 1992-03-24 1992-03-24 N-[2-amino-4-substituted[[(pyrrollo or pyrido)[2,3-d]pyrimidinyl]-alkyl]benzoyl]-L-glutamic acids

Publications (2)

Publication Number Publication Date
HU9300804D0 HU9300804D0 (en) 1993-06-28
HUT70036A true HUT70036A (en) 1995-09-28

Family

ID=25324069

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9300804A HUT70036A (en) 1992-03-24 1993-03-19 N-[[2-amino-4-substituted-pyrrolo[2,3-d]pyrimidinyl-or pyrido[2,3-d]pyrimidinyl]-alkyl-benzoyl]-l-glutamic-acid derivatives, process for producing them and pharmaceutical preparations containing them

Country Status (18)

Country Link
US (1) US5196424A (enExample)
EP (1) EP0567223A1 (enExample)
JP (1) JPH0625246A (enExample)
KR (1) KR930019676A (enExample)
CN (1) CN1078235A (enExample)
AU (1) AU3542993A (enExample)
BR (1) BR9301273A (enExample)
CA (1) CA2091978A1 (enExample)
CZ (1) CZ44093A3 (enExample)
FI (1) FI931251L (enExample)
HU (1) HUT70036A (enExample)
IL (1) IL105100A0 (enExample)
MX (1) MX9301544A (enExample)
MY (1) MY131322A (enExample)
NO (1) NO931008L (enExample)
NZ (1) NZ247193A (enExample)
TW (1) TW224098B (enExample)
ZA (1) ZA931944B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457056A (en) * 1993-07-06 1995-10-10 Fiberchem, Inc. Halohydrocarbon sensing chemistry with base modifier
US6537999B2 (en) * 1996-06-06 2003-03-25 Duquesne University Of The Holy Ghost Pyrimidine derivatives and methods of making and using these derivatives
EP0923287A4 (en) * 1996-08-30 2001-08-01 Lilly Co Eli NON-CLASSIC PYRROLO (2,3-D) PYRIMIDINE ANTIFOLATE
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US8030319B2 (en) * 2005-02-10 2011-10-04 Duquesne University Of The Holy Ghost Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2 3-d]pyrimidines
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
CN1962658B (zh) * 2005-11-10 2010-05-12 北京大学 一种四氢吡啶并[3,2-d]嘧啶类化合物及制备抗肿瘤药物的用途
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
WO2011056957A2 (en) * 2009-11-06 2011-05-12 Chelsea Therapeutics, Inc. Enzyme inhibiting compounds
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN102977107B (zh) * 2012-12-25 2015-04-22 山西普德药业股份有限公司 一种培美曲塞二钠化合物及其组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0119591B1 (en) * 1983-03-17 1988-06-22 Takeda Chemical Industries, Ltd. Thiodeazapurine derivatives
JPS59170091A (ja) * 1983-03-17 1984-09-26 Takeda Chem Ind Ltd ６−チオ−７−デアザプリン誘導体およびその製造法
WO1985002844A1 (en) * 1983-12-27 1985-07-04 Sri International 8,10-dideazaminopterins
US5026851A (en) * 1985-03-08 1991-06-25 The Trustees Of Princeton University Pyrido[2,3-]pyrimidine derivatives
US4684653A (en) * 1985-03-08 1987-08-04 The Trustees Of Princeton University Pyrido(2,3-d)pyrimidine derivatives
US4927828A (en) * 1985-03-08 1990-05-22 The Trustees Of Princeton University Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives
ZA861235B (en) * 1985-03-08 1986-10-29 Univ Princeton Pyrido(2,3-d)pyrimidine derivatives
US4988702A (en) * 1986-08-26 1991-01-29 Warner-Lambert Company Novel 9-deazaguanines
US4923872A (en) * 1986-08-26 1990-05-08 Warner-Lambert Co. Analogues of pyrrolo[3,2d]pyrimidin-4-ones
US4902796A (en) * 1986-10-20 1990-02-20 The Trustees Of Princeton University 6-alkenyl and ethynyl derivatives of 2-amino-4-hydroxypyrido[2,3-d]pyrimidines
US4988813A (en) * 1986-10-20 1991-01-29 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
US4921858A (en) * 1986-10-24 1990-05-01 Warner-Lambert Company 7-deazaguanines as immunomodulators
JP2830008B2 (ja) * 1988-04-01 1998-12-02 武田薬品工業株式会社 縮合ピリミジン誘導体
NO169490C (no) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater
US4882333A (en) * 1988-05-25 1989-11-21 The Trustess Of Princeton University N-(5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl-alkanoyl)-glutamic acid derivatives
CH677140A5 (enExample) * 1988-10-11 1991-04-15 W & E Umwelttechnik Ag
AU641183B2 (en) * 1989-09-19 1993-09-16 Teijin Limited Pyrrolo(2,3-d)pyrimidine derivative, process for preparing the same, and pharmaceutical preparation comprising the derivative as active ingredient
CA2032695A1 (en) * 1989-12-20 1991-06-21 Hiroshi Akimoto Condensed heterocyclic compounds, their production and use

Also Published As

Publication number Publication date
JPH0625246A (ja) 1994-02-01
MY131322A (en) 2007-08-30
CA2091978A1 (en) 1993-09-25
EP0567223A1 (en) 1993-10-27
MX9301544A (es) 1994-07-29
NO931008D0 (no) 1993-03-19
HU9300804D0 (en) 1993-06-28
NO931008L (no) 1993-09-27
IL105100A0 (en) 1993-12-28
ZA931944B (en) 1994-09-18
FI931251A7 (fi) 1993-09-25
NZ247193A (en) 1995-05-26
KR930019676A (ko) 1993-10-18
FI931251L (fi) 1993-09-25
CZ44093A3 (en) 1994-02-16
AU3542993A (en) 1993-09-30
US5196424A (en) 1993-03-23
BR9301273A (pt) 1993-09-28
FI931251A0 (fi) 1993-03-22
TW224098B (enExample) 1994-05-21
CN1078235A (zh) 1993-11-10

Similar Documents

Publication Publication Date Title
EP0964864B1 (en) Pyrido 2,3-d pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
WO2022031678A1 (en) Kras g12d inhibitors
TW202138367A (zh) 經取代之直鏈螺環接衍生物
EP2966079B1 (en) Pyridopyrimidine or pyrimidopyrimidine compound, preparation method, pharmaceutical composition and use thereof
EP0215063B1 (en) PYRIDO (2,3-d )PYRIMIDIN DERIVATIVES
CZ139097A3 (cs) 6-Arylpyrido[2,3-d]pyrimidiny a naftyridiny a farmaceutické prostředky na jejich bázi
EP0923287A1 (en) Nonclassical pyrrolo 2,3-d]pyrimidine antifolates
CN110156813A (zh) 作为trk抑制剂的杂环化合物
US7618982B2 (en) Heteroarylpyrrolopyridinones active as kinase inhibitors
TWI508966B (zh) 三衍生物
EP0327190B1 (en) Pyrido(2,3-d)pyrimidine derivatives
CN119546608A (zh) 新颖咪唑并吡啶和吡唑并吡啶磺酰胺衍生物
HU205358B (en) Process for producing pyrrolopyrimidines and pharmaceutical compositions comprising such compounds
US5196424A (en) N-[2-amino-4-substituted[[(pyrrollo or pyrido)[2,3-d]pyrimidinyl]-alkyl]benzoyl]-L-glutamic acids
CN118852178A (zh) 用于治疗诸如癌症的疾病的化合物
US4536575A (en) 2-Amino-4(3H)-oxopyrido[2,3-d]pyrimidino
CA2286909A1 (en) 5,7-disubstituted 4-aminopyrido¬2,3-d|pyrimidine compounds and their use as adenosine kinase inhibitors
EP4378943A1 (en) 8-oxo-3-azabicyclo[3.2.1]octane compound or salt thereof, and preparation method therefor and use thereof
US4431805A (en) Pyrido[2,3-d]-pyrimidines
EP1492793B1 (en) New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives
JPH08828B2 (ja) 抗腫瘍活性を高めるための複素環化合物
US4526964A (en) 2,4-Diamino-6-(hydroxymethyl)pyrido[2,3-d]pyrimidine
AU730345B2 (en) Naphthyridine derivatives
US6306847B1 (en) Condensed purine derivatives
EP0075880B1 (en) Pyrido (2,3-d) pyrimidines

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee